DexCom Inc (DXCM)

Current ratio

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Total current assets US$ in thousands 4,425,900 4,698,400 5,002,900 3,767,400 3,668,800 3,398,500 3,808,700 3,746,600 3,684,400 3,656,200 3,474,200 3,445,100 3,424,800 3,237,100 3,033,000 1,995,700 1,969,400 1,815,700 1,744,200 1,690,800
Total current liabilities US$ in thousands 1,556,000 1,678,600 2,069,700 1,865,000 1,839,300 900,500 807,000 711,400 720,800 734,900 600,700 604,100 614,100 506,400 400,100 342,800 360,200 322,400 288,200 235,400
Current ratio 2.84 2.80 2.42 2.02 1.99 3.77 4.72 5.27 5.11 4.98 5.78 5.70 5.58 6.39 7.58 5.82 5.47 5.63 6.05 7.18

December 31, 2023 calculation

Current ratio = Total current assets ÷ Total current liabilities
= $4,425,900K ÷ $1,556,000K
= 2.84

The current ratio of Dexcom Inc has shown fluctuations over the past eight quarters, ranging from a low of 1.99 in Q4 2022 to a high of 5.27 in Q1 2022. The current ratio measures the company's ability to meet its short-term obligations with its current assets.

In recent quarters, Dexcom Inc has maintained a relatively healthy current ratio, indicating a strong ability to cover its short-term liabilities with its current assets. The current ratio has generally been above 2, which is considered a good benchmark for most industries.

However, there was a decline in the current ratio from Q2 2023 to Q4 2023, which may raise concerns about the company's liquidity position in the short term. It is important for investors and stakeholders to monitor the trend in the current ratio over time to assess Dexcom Inc's ability to manage its short-term financial obligations effectively.


Peer comparison

Dec 31, 2023


See also:

DexCom Inc Current Ratio (Quarterly Data)